(Q33857609)

29 July 2017

1 reference

title

TGF-beta in diabetic kidney disease: role of novel signaling pathways (English)

1 reference

29 July 2017

1 reference

Sharma K

1

1 reference

PubMed ID

10708959

29 July 2017

McGowan TA

series ordinal

2

1 reference

29 July 2017

1 March 2000

1 reference

Cytokine and Growth Factor Reviews

29 July 2017

1 reference

29 July 2017

11

1 reference

29 July 2017

1-2

1 reference

29 July 2017

115-123

1 reference

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900035-0

7 January 2021

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900035-0

7 January 2021

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900035-0

7 January 2021

Nephropathy in patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900035-0

7 January 2021

Sequential renal biopsies in insulin-dependent diabetic patients: structural factors associated with clinical progression

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900035-0

7 January 2021

Interstitial pathomechanisms underlying progressive tubulointerstitial damage

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900035-0

7 January 2021

Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-beta

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900035-0

7 January 2021

Transcriptional activation of transforming growth factor-beta1 in mesangial cell culture by high glucose concentration

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900035-0

7 January 2021

Differential roles of upstream stimulatory factors 1 and 2 in the transcriptional response of liver genes to glucose

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900035-0

7 January 2021

Expression of transforming growth factor-beta 1 during diabetic renal hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900035-0

7 January 2021

Sustained expression of TGF-beta 1 underlies development of progressive kidney fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900035-0

7 January 2021

Transforming growth factor-beta 1 expression and phenotypic modulation in the kidney of hypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900035-0

7 January 2021

Transforming growth factor beta 1 and renal injury following subtotal nephrectomy in the rat: role of the renin-angiotensin system

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900035-0

7 January 2021

Increased expression of TGF-beta 1 mRNA in the obstructed kidney of rats with unilateral ureteral ligation

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900035-0

7 January 2021

Quantification of glomerular TGF-beta 1 mRNA in patients with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900035-0

7 January 2021

Expression of transforming growth factor-beta isoforms in human glomerular diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900035-0

7 January 2021

Plasma leptin is partly cleared by the kidney and is elevated in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900035-0

7 January 2021

The role of angiotensin II in diabetic nephropathy: emphasis on nonhemodynamic mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900035-0

7 January 2021

Losartan decreases plasma levels of TGF-beta1 in transplant patients with chronic allograft nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900035-0

7 January 2021

Captopril-induced reduction of serum levels of transforming growth factor-beta1 correlates with long-term renoprotection in insulin-dependent diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900035-0

7 January 2021

Transforming growth factor-beta1 stimulates protein kinase A in mesangial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900035-0

7 January 2021

Transforming growth factor-beta1 and glial growth factor 2 reduce neurotrophin-3 mRNA expression in cultured Schwann cells via a cAMP-dependent pathway.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900035-0

7 January 2021

The transcriptional activity of NF-kappaB is regulated by the IkappaB-associated PKAc subunit through a cyclic AMP-independent mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900035-0

7 January 2021

TGF-beta induces fibronectin synthesis through a c-Jun N-terminal kinase-dependent, Smad4-independent pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900035-0

7 January 2021

Stimulation of Type I Collagen Transcription in Human Skin Fibroblasts by TGF-β: Involvement of Smad 3

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900035-0

7 January 2021

TGF-beta1-induced cell cycle arrest in renal mesangial cells involves inhibition of cyclin E-cdk 2 activation and retinoblastoma protein phosphorylation

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900035-0

7 January 2021

Inositol trisphosphate and calcium signalling

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900035-0

7 January 2021

The inositol triphosphate receptor family

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900035-0

7 January 2021

Localization of inositol 1,4,5-trisphosphate receptors in the rat kidney

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900035-0

7 January 2021

Growth arrest of a murine mesangial cell line by transforming growth factor beta 1 is associated with inhibition of mitogen-induced Ca2+ mobilization

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900035-0

7 January 2021

Transforming growth factor beta 1 modulates angiotensin II-induced calcium influx in vascular smooth muscle

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900035-0

7 January 2021

Transforming growth factor-beta1 inhibits type I inositol 1,4,5-trisphosphate receptor expression and enhances its phosphorylation in mesangial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900035-0

7 January 2021

Cyclic AMP-dependent phosphorylation of a brain inositol trisphosphate receptor decreases its release of calcium

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900035-0

7 January 2021

Renal type I inositol 1,4,5-trisphosphate receptor is reduced in streptozotocin-induced diabetic rats and mice

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900035-0

7 January 2021

The recombinant proregion of transforming growth factor beta1 (latency-associated peptide) inhibits active transforming growth factor beta1 in transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900035-0

7 January 2021

Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900035-0

7 January 2021

The activation sequence of thrombospondin-1 interacts with the latency-associated peptide to regulate activation of latent transforming growth factor-beta

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900035-0

7 January 2021

Treatment of idiopathic pulmonary fibrosis with a new antifibrotic agent, pirfenidone: results of a prospective, open-label Phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900035-0

7 January 2021

10.1016/S1359-6101(99)00035-0

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10708959